跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12 条关于
“SAILEXIN”
全部
12
临床试验
2
药物
0
机构
0
资讯
10
去年
Qyuns Therapeutics' Ustekinumab Biosimilar Approved in China for Psoriasis Treatment
2年前
FDA Grants Breakthrough Therapy Designation to Sanbexin Sublingual Tablets for Acute Ischemic Stroke
2年前
FDA Grants Breakthrough Therapy Designation to Sanbexin for Acute Ischemic Stroke
2年前
Sanbexin Sublingual Tablets Granted FDA Breakthrough Therapy Designation for Ischemic Stroke
去年
Simcere's Sanbexin Receives FDA Breakthrough Therapy Designation for Acute Ischemic Stroke
9个月前
Silexion Therapeutics Receives German Regulatory Approval for Phase 2/3 Pancreatic Cancer Trial Design
去年
Silexion's LODER Shows Promise in Non-Resectable Pancreatic Cancer
去年
Silexion Therapeutics Partners with AMS for Phase 2/3 Trials of KRAS-Targeting siRNA Therapy SIL204
6个月前
Silexion Therapeutics Receives Israeli Regulatory Approval for Phase 2/3 Trial of KRAS-Targeting RNAi Therapy SIL204
去年
SIL-204 Demonstrates Synergy with Chemotherapy in KRAS-Driven Pancreatic Cancer Models